Melisa Wong Points Out Potential Age Bias in Active Treatment of Lung Cancer

September 22, 2016
Melisa Wong, MD

Melisa Wong lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.

Melisa Wong, MD, of the University of California, San Francisco, lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.

The study found that for every 10-year increase in age, a patient was 25% less likely to receive active care—a patient aged 70 years was 25% more likely than one aged 80 to receive active treatment for their cancer. She suggests that age bias, among other reasons, could be responsible for this gap.